Explore the Science, Evidence, and Future of Biologic Technologies in Spine Care

The field of spinal biologics is rapidly evolving as patients, researchers, and clinicians are recognizing its potential to treat challenging painful conditions. While the roles of both nonoperative and surgical treatment are relatively well-defined in the algorithm of spine care, the indications, risks, and concerns regarding biologics for a variety of spinal conditions have not been agreed upon. Because of the differences in regulatory pathways for many of these products, the availability of data is variable making administrative decision-making difficult. This meeting will bring together exciting minds from academia and industry to discuss the pertinent technologies and relevant issues in biologics use for spinal conditions.

Those who attend will learn:

  • Review the evidence supporting current osteobiologics and graft materials used in spine care;
  • Understand regulatory and translational challenges affecting biologics adoption;
  • Explore emerging regenerative and disc restoration technologies;
  • Assess how implants, surface technologies, and patient factors influence fusion outcomes

The program provides a forum for interdisciplinary discussion among stakeholders shaping the future of spine biologics.

Who Should Attend?

Researchers
Engineers
Spine Surgeons
Corporate Leadership
Regulatory Affairs and Reimbursement Professionals
Industry Scientists and Developers
Residents and Fellows
Early-career Investigators Engaged in Biologics, Biomaterials, and Regenerative Spine Technologies 

Registration Information

Non CME Course

Register Now

Sonesta Nashville Airport
Hotel Cutoff: October 19, 2026

Book Your Stay at Sonesta Nashville Airport

$189 - Includes Free shuttle to and from airport and 15 minute drive to Downtown Nashville
Address: 600 Marriott Drive | Nashville, TN 37214
United Airlines Partnership